FDA
approval
· 2021-01-13
FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Strides Pharma Science Limited)
Summary
FDA approved a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate under an original ANDA from Strides Pharma Science Limited for …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)